Associate Data Scientist
Amgen
Associate Data Scientist
Amgen
Makes biotech medicines for serious illnesses
Level: Associate (L3)
Role: Marketing Investment Optimization – Investment Analytics
MIO OVERVIEW
The Marketing Investment Optimization (MIO) vertical at Amgen is responsible for enabling data‑driven, decision‑grade marketing investment decisions across brands, channels, and portfolios.
MIO brings together Investment Analytics (IA), Media Analytics (MA), and Marketing Science Operations (MSO) to measure effectiveness, quantify incrementality, and optimize marketing investments.
MIO focuses on marketing mix modelling (MMx), Experimentation and Causal Measurement, Optimization, Media and Campaign analytics, Scenario Planning, ensuring that marketing dollars are allocated to maximize business impact. The team partners closely with Brand Marketing, GCC/Agencies, CD&A, and MSO to translate complex analytics into actionable investment decisions.
Role Summary
The Associate – Investment Analytics role is an entry‑level analytics position within the Investment Analytics team. This role is ideal candidates who are excited about applying analytical thinking, structured problem solving, and data skills to real‑world business questions.
The team will provide structured learning and on‑the‑job exposure. What matters most is curiosity, critical thinking, and a strong learning mindset.
LIVE | WHAT YOU WILL DO
As an Associate, you will work under guidance from Senior Associates and Managers to support analytical deliverables and build strong foundations in applied analytics.
You will:
BASIC QUALIFICATIONS
Preferred Qualifications
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen